Form 8-K

8-K — Aimei Health Technology Co., Ltd.

Accession: 0001493152-26-024600

Filed: 2026-05-20

Period: 2026-05-19

CIK: 0001979005

SIC: 6770 (BLANK CHECKS)

Item: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item: Financial Statements and Exhibits

Documents

8-K — form8-k.htm (Primary)

EX-99.1 (ex99-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: form8-k.htm · Sequence: 1

false

0001979005

2026-05-19

0001979005

AFJK:OrdinarySharesParValue0.0001PerShareMember

2026-05-19

0001979005

AFJK:RightsExchangeableIntoOnefifthOfOneOrdinaryShareMember

2026-05-19

0001979005

AFJK:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember

2026-05-19

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

United

States

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

Form

8-K

Current

Report

Pursuant

to Section 13 or 15(d) of the

Securities

Exchange Act of 1934

May

19, 2026

Date

of Report (Date of earliest event reported)

AIMEI

HEALTH TECHNOLOGY CO., LTD

(Exact

Name of Registrant as Specified in its Charter)

Cayman

Islands

001-41880

00-0000000 N/A

(State

or other jurisdiction

incorporation)

(Commission

File

Number)

(I.R.S.

Employer

Identification

No.)

East 53rd Street, Suite 3001

New

York, NY

10022

(Address

of Principal Executive Offices)

(Zip

Code)

86-13758131392

Registrant’s

telephone number, including area code

N/A

(Former

name or former address, if changed since last report)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions:

☐

Written

communications pursuant to Rule 425 under the Securities Act

☐

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act

☐

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act

☐

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each Class

Trading

Symbol(s)

Name

of each exchange on which registered

Ordinary

Shares, par value $0.0001 per share

AFJK

The

Nasdaq Stock Market LLC

Rights,

exchangeable into one-fifth of one Ordinary Share

AFJKR

The

Nasdaq Stock Market LLC

Units,

each consisting of one Ordinary Share and one Right

AFJKU

The

Nasdaq Stock Market LLC

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)

or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging

growth company ☒

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

May 19, 2026, Aimei Health Technology Co., Ltd (the “Company”) received a notice (the “Notice”)

from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”),

notifying the Company that because the Company had not yet filed its Quarterly Report on Form 10-Q for the quarterly period ended March

31, 2026 (the “Quarterly Report”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the

“Listing Rule”) requiring Nasdaq-listed companies to timely file all periodic financial reports with the U.S. Securities

and Exchange Commission (the “SEC”). The Quarterly Report was due on May 15, 2026.

The

Notice has no immediate effect on the listing or trading of the Company’s securities on Nasdaq. However, if the Company fails to

timely regain compliance with the Listing Rule, the Company’s securities will be subject to delisting from Nasdaq.

Under

the Nasdaq rules, the Company has 60 calendar days from the date of the Notice either to file the Quarterly Report or to submit a plan

to Nasdaq to regain compliance with Nasdaq’s listing rules. If a plan is submitted and accepted, the Company could be granted up

to 180 calendar days from the Quarterly Report’s due date to regain compliance. If Nasdaq does not accept the Company’s plan,

the Company will have the opportunity to appeal that decision to a Nasdaq hearings panel.

While

the Company can provide no assurances as to timing, the Company is working diligently to complete and file the Quarterly Report and expects

to regain compliance with the Listing Rule.

May 20, 2026, the Company issued a press release in accordance with Nasdaq Listing Rule 5810(b) announcing that it had received the Notice.

A copy of the press release is attached hereto as Exhibit 99.1.

Cautionary

Statement Regarding Forward-Looking Statements

This

Current Report on Form 8-K may contain “forward-looking” statements within the meaning of Section 21E of the Securities Exchange

Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. Forward-looking statements provide management’s

current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical

or current fact. Statements containing words such as “believe,” “intend,” “plan,” “may,”

“expect,” “should,” “could,” “anticipate,” “estimate,” “predict,”

“project,” or their negatives, or other similar expressions of a future or forward-looking nature, generally should be considered

forward-looking statements. The forward-looking statements in this Current Report are based on management’s current expectations

and assumptions about future events that involve inherent risks and uncertainties. While the Company considers these expectations and

assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory, and other risks

and uncertainties, most of which are difficult to predict and many of which are beyond the Company’s control. The Company undertakes

no obligation to review or update any forward-looking statements, whether as a result of new information, future events, or otherwise,

unless required by law.

Item

9.01 Exhibits.

(d)

Exhibits

Exhibit

No.

Description

99.1

Press Release dated May 20, 2026

104

Cover

Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

Date:

May 20, 2026

Aimei

Health Technology Co., Ltd

By:

/s/

Junheng Xie

Name:

Junheng

Xie

Title:

Chief

Executive Officer and Director

(Principal

Executive Officer)

EX-99.1

Filename: ex99-1.htm · Sequence: 2

Exhibit

99.1

AIMEI

HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORT

New

York, NY – May 20, 2026 – Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that

on May 19, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market

LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for

the period ended March 31, 2026 (the “Quarterly Report”) with the U.S. Securities and Exchange Commission (the “SEC”),

the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing

Rule”). The Quarterly Report was due on May 15, 2026.

The

Notice has no immediate effect on the listing or trading of the Company’s securities on Nasdaq. However, if the Company fails to

timely regain compliance with the Listing Rule, the Company’s securities will be subject to delisting from Nasdaq.

Under

Nasdaq rules, the Company has 60 calendar days from the date of the Notice to either file the Quarterly Report or submit a plan to Nasdaq

to regain compliance with Nasdaq’s listing rules. If a plan is submitted and accepted, the Company may be granted up to 180 calendar

days from the Quarterly Report’s due date to regain compliance. If Nasdaq does not accept the Company’s plan, the Company

will have the opportunity to appeal that decision to a Nasdaq hearings panel.

The

Company is working diligently to complete and file the Quarterly Report and expects to regain compliance with the Listing Rule.

This

announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.

About

Aimei Health Technology Co., Ltd

Aimei

Health Technology Co., Ltd is a blank check company incorporated as a Cayman Islands exempted company with limited liability for the

purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business

combination with one or more businesses or entities. The Company’s efforts to identify a prospective target business will not be

limited to a particular industry or geographic region, although the Company intends to pursue prospective targets focused on healthcare

innovation.

Forward-Looking

Statements

This

press release contains “forward-looking” statements within the meaning of the federal securities laws. These statements are

based on management’s current expectations and assumptions and involve risks and uncertainties that could cause actual results

to differ materially from those expressed or implied. The Company undertakes no obligation to update any forward-looking statements except

as required by applicable law.

For

investor and media inquiries, please contact:

Aimei

Health Technology Co., Ltd

East 53rd Street, Suite 3001

New

York, NY 10022

Attention:

Junheng Xie

Email:

Xiejunheng@aimeihealth.com

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.1

Cover

May 19, 2026

Document Type

8-K

Amendment Flag

false

Document Period End Date

May 19, 2026

Entity File Number

001-41880

Entity Registrant Name

AIMEI

HEALTH TECHNOLOGY CO., LTD

Entity Central Index Key

0001979005

Entity Tax Identification Number

00-0000000

Entity Incorporation, State or Country Code

Entity Address, Address Line One

East 53rd Street

Entity Address, Address Line Two

Suite 3001

Entity Address, City or Town

New

York

Entity Address, State or Province

Entity Address, Postal Zip Code

10022

City Area Code

Local Phone Number

13758131392

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

Ordinary Shares, par value $0.0001 per share

Title of 12(b) Security

Ordinary

Shares, par value $0.0001 per share

Trading Symbol

AFJK

Security Exchange Name

NASDAQ

Rights, exchangeable into one-fifth of one Ordinary Share

Title of 12(b) Security

Rights,

exchangeable into one-fifth of one Ordinary Share

Trading Symbol

AFJKR

Security Exchange Name

NASDAQ

Units, each consisting of one Ordinary Share and one Right

Title of 12(b) Security

Units,

each consisting of one Ordinary Share and one Right

Trading Symbol

AFJKU

Security Exchange Name

NASDAQ

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=AFJK_OrdinarySharesParValue0.0001PerShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=AFJK_RightsExchangeableIntoOnefifthOfOneOrdinaryShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=AFJK_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: